Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYellow Cake Regulatory News (YCA)

Share Price Information for Yellow Cake (YCA)

Share Price is delayed by 15 minutes
Get Live Data
545.50    9.00 (1.68%)
Bid:
545.00
Ask:
546.00
Spread: 1.00 (0.183%)
Market Cap: £1.38b
YCA Live PriceLast checked at - London Stock Exchange

Intraday Yellow Cake Share Chart

Share Buyback Programme extension

4 May 2022 11:53

RNS Number : 3063K
Yellow Cake PLC
04 May 2022
 

4 May 2022

 

 

Yellow Cake plc ("Yellow Cake" or the "Company")

Yellow Cake extends timeframe for completion of US$3 million Share Buyback Programme

Yellow Cake, a specialist company operating in the uranium sector holding physical uranium for the long term, announces the extension of its share buyback programme to purchase up to US$3 million of the Company's ordinary shares of £0.01 pence each ("Ordinary Shares") (the "Programme").

The Programme commenced on 4 April 2022 and ran for an initial period of 30 calendar days. During the Programme, the Company purchased in aggregate 432,331 Ordinary Shares for a total consideration of US$2.3 million, at a volume weighted average price of 422.7 pence per share and a volume weighted average discount to net asset value of 11.5%. The Company has now decided to extend the Programme for an additional 30 calendar days commencing today, subject to early termination if the Company completes the purchase of US$3 million Ordinary Shares in aggregate from commencement of the Programme.

The Company's shares have traded at a material discount to its underlying net asset value since mid-January this year. The Yellow Cake Board therefore took the decision to implement the Programme as a means of effectively acquiring exposure to uranium at a discount to the commodity spot price. The Programme forms part of the Company's stated broader strategy to deliver value to its shareholders. 

The Company has 187,740,730 Ordinary Shares in issue, of which 4,501,829 are held in treasury. Therefore, the total number of Ordinary Shares carrying voting rights is 183,238,901.

Purchases pursuant to the Programme will be made under the authority the Company has in place to make market acquisitions in accordance with the Jersey Companies Law (the "Existing Authority"). The parameters of the Programme will remain as previously announced on 4 April 2022 and the Company will seek to make market purchases at a price or prices and volume that the Company believes to be value-enhancing for the Company's shareholders. As such, it is the Company's intention that Ordinary Shares only be purchased should the closing mid-market share price of the Company in any given day represent a discount of 10% or more to the Company's proforma Net Asset Value at that time.

The Existing Authority permits the purchase of a maximum of 15,358,435 Ordinary Shares, including purchases made to date under the Programme. The Programme is being conducted in compliance with the Market Abuse Regulation (EU) No. 596/2014 and Commission Delegated Regulation (EU) No. 2016/1052, as they form part of UK law. The Company intends to hold those Ordinary Shares purchased under the Programme in treasury.

Purchases are being carried out in compliance with the relevant conditions for trading, restrictions regarding time and volume, disclosure and reporting obligations, and price conditions. The Ordinary Shares are being repurchased at a price, excluding expenses, that does not exceed the higher of (i) the last independent trade or the highest current independent bid on the relevant trading platform; and (ii) 105 percent of the average market value of an Ordinary Share as derived from the AIM Appendix to the London Stock Exchange Daily Official List for the five business days immediately preceding the date of purchase.

Details of any purchases made under the Programme will continue to be provided via RNS announcements and published on the Company's website.

 

Yellow Cake plc

 

 

Andre Liebenberg, CEO

Tel: +44 (0) 153 488 5200

Carole Whittall, CFO

 

 

Nominated Adviser and Joint Broker: Canaccord Genuity Limited

 

Henry Fitzgerald-O'Connor

Gordon Hamilton

Tel: +44 (0) 207 523 8000

 

James Asensio

 

 

Joint Broker: Berenberg

 

Matthew Armitt

Detlir Elezi

Tel: +44 (0) 203 207 7800

Jennifer Wyllie

 

 

Financial Adviser: Bacchus Capital Advisers

 

Peter Bacchus

Richard Allan

Tel: +44 (0) 203 848 1640

 

 

 

Investor Relations: Powerscourt

 

 

 

Peter Ogden

Tel: +44 (0) 7793 858 211

Molly Melville

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEAESLESFAEFA
Date   Source Headline
28th Dec 20227:00 amRNSYELLOW CAKE RECEIVES DTC ELIGIBILITY
7th Dec 20227:00 amRNSInterim Report
9th Nov 20229:29 amRNSChanges to the Board of Directors
4th Nov 20227:00 amRNSAward of Share Options
31st Oct 20227:00 amRNSQuarterly Operating Update
7th Sep 202211:27 amRNSResults of 2022 Annual General Meeting
29th Jul 20227:00 amRNSNotice of AGM & Publication of 2022 Annual Report
28th Jul 20227:00 amRNSQUARTERLY OPERATING UPDATE
22nd Jul 20227:00 amRNSAnnual Results for the year ended 31 March 2022
15th Jul 20229:00 amRNSTR1: Notification of Major Holdings
1st Jul 20227:00 amRNSDELIVERY OF 950,000 LB OF U3O8
22nd Jun 20227:00 amRNSCOMMENCEMENT OF TRADING ON OTCQX
20th May 20227:00 amRNSDELIVERY OF URANIUM
10th May 20227:00 amRNSTR-1: Notification of major holdings
9th May 20227:00 amRNSCompletion of Buyback Programme
6th May 20223:10 pmRNSTransaction in Own Shares
6th May 20227:00 amRNSTransaction in Own Shares
5th May 20227:00 amRNSTransaction in Own Shares
4th May 202211:53 amRNSShare Buyback Programme extension
4th May 20227:00 amRNSTransaction in Own Shares
29th Apr 20227:00 amRNSTransaction in Own Shares
27th Apr 20227:00 amRNSQUARTERLY OPERATING UPDATE
26th Apr 20226:22 pmRNSNOTIFICATION OF MAJOR HOLDINGS
25th Apr 20227:00 amRNSTransaction in Own Shares
22nd Apr 20227:00 amRNSTransaction in Own Shares
21st Apr 20227:00 amRNSTransaction in Own Shares
4th Apr 20227:00 amRNSUS$3 million Share Buyback Programme
4th Mar 20227:00 amRNSUpdate regarding 2021 Director Re-election
31st Jan 20227:00 amRNSQuarterly Operating Update
27th Jan 202211:40 amRNSResults of 2022 General Meeting
11th Jan 20227:00 amRNSNotice of General Meeting
9th Dec 20217:00 amRNSInterim Financial Report
22nd Nov 20217:00 amRNSExercise of Repurchase Option and Buyback Option
15th Nov 20215:16 pmRNSTR-1: Notification of major holdings
8th Nov 20217:00 amRNSQUARTERLY OPERATING UPDATE
3rd Nov 20217:00 amRNSTR-1: Notification of major holdings
3rd Nov 20217:00 amRNSTR-1: Notification of major holdings
29th Oct 20217:00 amRNSPurchase of 2mlb U3O8 at US$46.32/lb
27th Oct 20217:21 amRNSResults of Placing
26th Oct 20216:14 pmRNSProposed Uranium Purchase and Placing
30th Sep 20217:00 amRNSTR-1: Notification of major holdings
16th Sep 20213:08 pmRNSTR-1: Notification of major holdings – Replacement
10th Sep 202110:33 amRNSTR-1: Notification of Major Holdings
8th Sep 202111:00 amRNSResults of AGM
27th Aug 20217:00 amRNSPurchase of 2 million lb U3O8 for US$32.23/lb
2nd Aug 20217:00 amRNSQUARTERLY OPERATING UPDATE
26th Jul 20217:01 amRNSGrant and Exercise of Share Options
26th Jul 20217:00 amRNSPublication of Annual Report and AGM Notice
19th Jul 20217:00 amRNSAnnual Results for the year ended 31 March 2021
24th Jun 202112:45 pmRNSTR-1: Notification of major holdings - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.